GLobal Assessment of Plaque reGression With a PCSK9 antibOdy as Measured by intraVascular Ultrasound
Clinical trial NCT01813422 · COMPLETED
Trial details
- NCT number
- NCT01813422
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-18
- Primary completion
- 2016-07-12
- Enrollment
- 970
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.